Biocon spinout Bicara Therapeutics snags $108 mn in Series B round

Bicara Therapeutics, a biotech firm floated by Kiran Mazumdar’s niece Claire Mazumdar, has secured $108 million in a Series B funding exercise. The startup had earlier raised an undisclosed capital in a seed round from Biocon, which was also its subsidiary, before spinning off in 2021.  The new round was co-led ......